European journal of gastroenterology & hepatology
-
Clostridium difficile is now established as the most common nosocomial enteric pathogen causing pseudomembranous colitis, antibiotic-associated colitis and antibiotic-associated diarrhoea. Antibiotic therapy is the most important risk factor in colonization and infection with C. difficile. However, other factors are involved such as age and underlying illness. The introduction of reliable typing and fingerprinting methods has demonstrated hospital acquisition and cross-infection with C. difficile and has been important in improving our understanding of the epidemiology and pathogenicity of C. difficile.
-
Eur J Gastroenterol Hepatol · Nov 1996
ReviewManagement of Clostridium difficile infection and other antibiotic-associated diarrhoeas.
Most cases of antibiotic-associated diarrhoea are due to Clostridium difficile or are enigmatic. Patients with C. difficile-associated disease are more likely to have colitis, severe disease and nosocomial acquisition. The preferred diagnostic test is a C. difficile toxin assay using a tissue culture assay or enzyme immunoassay. ⋯ Response rates approach 100%; the major complication is relapse. Major complications include toxic megacolon, devastating diarrhoea, pseudomembranous colitis and hypoalbuminemia. Antibiotic-associated diarrhoea with negative tests for C. difficile toxin is usually dose-related and responds to antibiotic withdrawal.